Educational guide
EBV LMP2 200-208 IEDPPFNSL Peptide for T Cell Assays
EBV LMP2 200-208 Peptide (HLA-B*40:01) - IEDPPFNSL US$178.10 Excluding tax and shipping fees In stock Description About EBV LMP2 200-208 Peptide (HLA-B*40:01) - IEDPPFNSL The Epstein-Barr Virus (EBV) Latent membrane protein 2 (LMP2) Peptide is a high quality e
This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.
EBV LMP2 200-208 Peptide (HLA-B*40:01) - IEDPPFNSL
US$178.10
Excluding tax and shipping fees
In stock
Description
About EBV LMP2 200-208 Peptide (HLA-B*40:01) - IEDPPFNSL
The Epstein-Barr Virus (EBV) Latent membrane protein 2 (LMP2) Peptide is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Latent membrane protein 2 (LMP2) Peptide, H-IEDPPFNSL-OH (Uniprot: P13285 aa: 200-208) from JPT is produced under strict quality control and quality management.
EBV LMP2 200-208 Peptide (HLA-B*40:01) - IEDPPFNSL - Specifications
Peptide sequence: H-IEDPPFNSL-OH
Amount: 1 mg
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Delivery Format: Freeze-dried in plastic vial
Application(s): Flow Cytometry
Condition(s)/Topic(s): Infectious disease, Cancer, Neuroscience
Standard Delivery Time: approx. 10 days
Visit our webpage for more information on Peptide Tools to Study EBV
Applications of EBV LMP-2 200-208 Antigen Peptide
This EBV LMP-2 peptide is optimized for a wide range of immunological and translational research applications, including:
ELISPOT assays for IFN-Y or cytokine detection
Intracellular Cytokine Staining (ICS)
Cytotoxicity assays (CTL killing assays)
T cell proliferation assays
Epitope mapping and immune monitoring
Vaccine and immunotherapy development
Your Custom or Scrambled Antigen Peptide!
Do you need a scrambled version of this antigen peptide?We can produce scrambled versions for all our antigen peptides and other peptide sequences. These scrambled peptide versions are cross-checked against the Uniprot database to ensure that the scrambled sequence does not correspond to any natural sequence. Have a look at Scrambled Antigen Peptides!
Are you interested in other antigen peptides?Choose sequence, amount and purity. We will assist you along the way: Custom Peptide Synthesis
JPT’s Antigen PeptidesFind your antigen peptide and select the connected PepMix™ Peptide Pool and MHC Multimer for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Benefits of JPT’s Antigen Peptides- All peptides are made in Germany- Bulk orders or custom peptide snythesis upon request- Synthesis protocols designed to avoid toxic contaminants and side products - Provision of freeze dried aliquots for enhanced stability - Proven track record for applications in clinical studies- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for EBV LMP2 200-208 Peptide (HLA-B*40:01) - IEDPPFNSL
References:Read References with Antigen Peptides
Documentation
Documentation for EBV LMP2 200-208 Peptide (HLA-B*40:01) - IEDPPFNSL
Protocol_PepMix.pdf
EBV-LMP2-200-208-Peptide-IEDPPFNSL-2.pdf
Properties
Properties of EBV LMP2 200-208 Peptide (HLA-B*40:01) - IEDPPFNSL
Antigen Peptides
Freeze-dried in plastic vial
Epstein-Barr Virus (EBV)
Latent membrane protein 2 (LMP2)
Trial Grade: each peptide purified to > 90% (HPLC/MS)
No
Further Information to EBV LMP2 200-208 Peptide (HLA-B*40:01) - IEDPPFNSL
Values
H-IEDPPFNSL-OH
Related Products
Related Products
EBV EBNA6 284-293 Peptide (HLA-A2) - LLDFVRFMGV
EBV BZLF1 209-217 Peptide (HLA-B*40:02) - SENDRLRLL
EBV BZLF1 54-64 Peptide (HLA-B*35:01) - EPLPQGQLTAY
EBV BZLF1 169-181 Peptide (HLA-B*18:01) - EECDSELEIKRY
EBV EBNA1 515-528 Peptide (HLA-DR1) - TSLYNLRRGTALAI
Antigen Peptide EBV EBNA1 HLA-B*3501 (HPVGEADYFEY)
EBV LMP2 340-349 Peptide - SSCSSCPLSK
EBV LMP2 356-364 Peptide (HLA-A*02:01) - FLYALALLL
EBV LMP2 419-427 Peptide (HLA-A*24:02) - TYGPVFMCL
EBV LMP2 426-434 Peptide (HLA-A*02:01) - CLGGLLTMV
EBV LMP2 131-139 Peptide (HLA-A*24:02) - PYLFWLAAI
EBV BZLF1 190-197 Peptide (HLA-B*08:01) - RAKFKQLL
EBV BMLF1 280-288 Peptide (HLA-A*02:01) - GLCTLVAML